Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sachi Horibata

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Molecular & Cellular Oncology|November 7, 2019
Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patientsSachi Horibata
Cells|October 28, 2025
Diverse Roles of Tubulin Polymerization Promoting Protein 3 (TPPP3) in Human Health and DiseaseJames W Lord, Sachi Horibata
Methods in Molecular Biology (Clifton, N.J.)|May 16, 2023
Sample Preparation and Differential Gene Expression Analysis of Human Cancer Cell Lines by RNA SequencingDmitry Leshchiner, Tommy V Vo, Sachi Horibata
The Journal of Reproduction and Development|July 14, 2012
Role for peptidylarginine deiminase enzymes in disease and female reproductionSachi Horibata, Scott A Coonrod, Brian D Cherrington
Cancer Drug Resistance (Alhambra, Calif.)|July 8, 2022
Mechanisms of chemotherapy resistance in ovarian cancerMylena Ortiz, Emma Wabel, Kerry Mitchell, et al.
Cancers|March 10, 2022
Targeting of RecQ Helicases as a Novel Therapeutic Strategy for Ovarian CancerJyotirindra Maity, Sachi Horibata, Grant Zurcher, et al.
Current Cancer Drug Targets|April 25, 2020
The Evolving AML Genomic Landscape: Therapeutic ImplicationsSachi Horibata, George Alyateem, Christin B DeStefano, et al.
Pharmacological Research|March 8, 2022
Cell cycle checkpoints and beyond: Exploiting the ATR/CHK1/WEE1 pathway for the treatment of PARP inhibitor-resistant cancerNitasha Gupta, Tzu-Ting Huang, Sachi Horibata, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|June 4, 2014
A novel role for protein arginine deiminase 4 in pluripotency: the emerging role of citrullinated histone H1 in cellular programmingDaniel J Slade, Sachi Horibata, Scott A Coonrod, et al.
Cancer Drug Resistance (Alhambra, Calif.)|January 13, 2025
Ovarian tumor microenvironment contributes to tumor progression and chemoresistanceAdriana Ponton-Almodovar, Samuel Sanderson, Ramandeep Rattan, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Molecular & Cellular Oncology|November 7, 2019
Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patientsSachi Horibata
Cells|October 28, 2025
Diverse Roles of Tubulin Polymerization Promoting Protein 3 (TPPP3) in Human Health and DiseaseJames W Lord, Sachi Horibata
Methods in Molecular Biology (Clifton, N.J.)|May 16, 2023
Sample Preparation and Differential Gene Expression Analysis of Human Cancer Cell Lines by RNA SequencingDmitry Leshchiner, Tommy V Vo, Sachi Horibata
The Journal of Reproduction and Development|July 14, 2012
Role for peptidylarginine deiminase enzymes in disease and female reproductionSachi Horibata, Scott A Coonrod, Brian D Cherrington
Cancer Drug Resistance (Alhambra, Calif.)|July 8, 2022
Mechanisms of chemotherapy resistance in ovarian cancerMylena Ortiz, Emma Wabel, Kerry Mitchell, et al.
Cancers|March 10, 2022
Targeting of RecQ Helicases as a Novel Therapeutic Strategy for Ovarian CancerJyotirindra Maity, Sachi Horibata, Grant Zurcher, et al.
Current Cancer Drug Targets|April 25, 2020
The Evolving AML Genomic Landscape: Therapeutic ImplicationsSachi Horibata, George Alyateem, Christin B DeStefano, et al.
Pharmacological Research|March 8, 2022
Cell cycle checkpoints and beyond: Exploiting the ATR/CHK1/WEE1 pathway for the treatment of PARP inhibitor-resistant cancerNitasha Gupta, Tzu-Ting Huang, Sachi Horibata, et al.
Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology|June 4, 2014
A novel role for protein arginine deiminase 4 in pluripotency: the emerging role of citrullinated histone H1 in cellular programmingDaniel J Slade, Sachi Horibata, Scott A Coonrod, et al.
Cancer Drug Resistance (Alhambra, Calif.)|January 13, 2025
Ovarian tumor microenvironment contributes to tumor progression and chemoresistanceAdriana Ponton-Almodovar, Samuel Sanderson, Ramandeep Rattan, et al.
Pageof 4